Article Information
History
- November 18, 2020.
Article Versions
- You are currently viewing Version 1 of this article (November 18, 2020 - 10:35).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Asgar Ansari1,6,
- Rakesh Arya2,6,
- Shilpa Sachan1,6,
- Someshwar Nath Jha1,6,
- Anurag Kalia1,
- Anupam Lall3,
- Alessandro Sette4,5,
- Alba Grifoni4,
- Daniela Weiskopf4,
- Poonam Coshic3,7,
- Ashok Sharma2,7 and
- Nimesh Gupta1,*
- 1Vaccine Immunology Laboratory, National Institute of Immunology, New Delhi, 110067, India
- 2Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, 110029, India
- 3Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, 110029, India
- 4Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA
- 5Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, 92037, USA
- ↵*Corresponding Author:
Dr. Nimesh Gupta, Vaccine Immunology Laboratory, National Institute of Immunology, New Delhi -110067, India. Email: nimesh.gupta{at}nii.ac.in